Obstetrics and Gynecology · Jul 12, 2026
The Intimate Dimension of Menopause
By Keye C
Menopause is associated with significant changes in intimate health, yet this area remains underrecognized in clinical practice. This chapter explores the impact of menopause on sexual well-being through a biopsychosocial lens, integrating physiological, psychological, and relationship factors. Declining estrogen levels contribute to genitourinary syndrome of menopause (GSM), altered tissue integrity, reduced lubrication, and pain, while changes in arousal, responsive desire, and orgasmic response may further affect sexual confidence and satisfaction. The chapter distinguishes libido from arousal and highlights the importance of avoiding narrow, penetration-focused models of sexual function. Assessment should be proactive, sensitive, and structured, incorporating symptoms, distress, relationship context, and validated tools such as the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS). Management requires an individualized approach that addresses GSM, pain, arousal difficulties, psychological well-being, and relational communication. Vaginal estrogen is a first-line treatment for GSM, with systemic hormone therapy and testosterone also potentially contributing to improvements in sexual well-being when clinically appropriate. Behavioral strategies, including self-stimulation, vibratory stimulation, and sensate focus, can support adaptation, confidence, and pleasure. Intimacy is framed broadly to include touch, connection, and nonpenetrative sexual expression. By normalizing discussion and providing evidence-based, inclusive care, clinicians can support individuals experiencing menopause to maintain meaningful and satisfying intimate lives.